首页> 外文期刊>International Journal of Radiation Oncology, Biology, Physics >Dosimetric benefits of intensity-modulated radiotherapy combined with the deep-inspiration breath-hold technique in patients with mediastinal Hodgkin's lymphoma
【24h】

Dosimetric benefits of intensity-modulated radiotherapy combined with the deep-inspiration breath-hold technique in patients with mediastinal Hodgkin's lymphoma

机译:纵隔霍奇金淋巴瘤患者调强放疗结合深呼吸屏气技术的剂量学优势

获取原文
获取原文并翻译 | 示例
           

摘要

Purpose: To assess the additional benefits of using the deep-inspiration breath-hold (DIBH) technique with intensity-modulated radiotherapy (IMRT) in terms of the protection of organs at risk for patients with mediastinal Hodgkin's disease. Methods and Materials: Patients with early-stage Hodgkin's lymphoma with mediastinal involvement were entered into the study. Two simulation computed tomography scans were performed for each patient: one using the free-breathing (FB) technique and the other using the DIBH technique with a dedicated spirometer. The clinical target volume, planning target volume (PTV), and organs at risk were determined on both computed tomography scans according to the guidelines of the European Organization for Research and Treatment of Cancer. In both cases, 30 Gy in 15 fractions was prescribed. The dosimetric parameters retrieved for the statistical analysis were PTV coverage, mean heart dose, mean coronary artery dose, mean lung dose, and lung V20. Results: There were no significant differences in PTV coverage between the two techniques (FB vs. DIBH). The mean doses delivered to the coronary arteries, heart, and lungs were significantly reduced by 15% to 20% using DIBH compared with FB, and the lung V20 was reduced by almost one third. The dose reduction to organs at risk was greater for masses in the upper part of the mediastinum. IMRT with DIBH was partially implemented in 1 patient. This combination will be extended to other patients in the near future. Conclusions: Radiation exposure of the coronary arteries, heart, and lungs in patients with mediastinal Hodgkin's lymphoma was greatly reduced using DIBH with IMRT. The greatest benefit was obtained for tumors in the upper part of the mediastinum. The possibility of a wider use in clinical practice is currently under investigation in our department.
机译:目的:评估将深呼吸屏气(DIBH)技术与强度调制放射疗法(IMRT)结合使用,在保护有纵隔霍奇金病风险的器官方面具有更多益处。方法和材料:患有纵隔累及的早期霍奇金淋巴瘤患者进入研究。对每位患者进行了两次模拟计算机断层扫描:一次使用自由呼吸(FB)技术,另一次使用带有专用肺活量计的DIBH技术。根据欧洲癌症研究与治疗组织的指南,在计算机X线断层扫描中确定了临床目标量,计划目标量(PTV)和有风险的器官。在这两种情况下,均规定了15馏分中的30 Gy。用于统计分析的剂量参数是PTV覆盖率,平均心脏剂量,平均冠状动脉剂量,平均肺部剂量和肺V20。结果:两种技术(FB与DIBH)之间的PTV覆盖率无显着差异。与FB相比,使用DIBH可以将传递到冠状动脉,心脏和肺的平均剂量显着降低15%至20%,并且将肺V20降低近三分之一。对于纵隔上部的肿块,对有风险器官的剂量减少更大。 1例患者部分实施了IMRT与DIBH。这种组合将在不久的将来扩展到其他患者。结论:采用IMRT的DIBH可以大大减少纵隔霍奇金淋巴瘤患者冠状动脉,心脏和肺部的辐射暴露。对于纵隔上部的肿瘤获得最大的益处。我们部门目前正在研究在临床实践中更广泛使用的可能性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号